Your Cart

IBX Secures Additional Capital — Shareholders Exercise Options

IBX Secures Additional Capital — Shareholders Exercise Options

Imagion Biosystems announces on ASX that it has received a total of $18,460.05 for the exercise of 363,201 Listed Options exercisable at 5 cents, expiring on 26 November 2021, and 10,000 Listed Options exercisable at 3 cents, expiring at 28 April 2023.

Please click to review the full announcement at ASX.

Related Articles

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.